Development of Novel Pharmacotherapies for the Treatment of Alcohol Dependence: Focus on Antiepileptics

Bankole A. Johnson, Robert M. Swift, Nassima Ait-Daoud, Carlo C. DiClemente, Martin A. Javors, Robert J. Malcolm

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

This article represents the proceedings of a symposium, "Development of Novel Pharmacotherapies for the Treatment of Alcohol Dependence: Focus on Antiepileptics," presented at the 2003 annual meeting of the Research Society on Alcoholism in Fort Lauderdale, FL. The organizers and cochairs were Bankole A. Johnson and Robert M. Swift. The presentations were (1) Development of topiramate in the treatment of alcoholism, by Bankole A. Johnson; (2) Craving as a predictor of treatment outcome in pharmacotherapy trials for the treatment of alcoholism, by Nassima Ait-Daoud; (3) Use of biomarkers as a predictor of treatment response in treating alcoholism, by Martin A. Javors; (4) Psychotherapy to enhance compliance with pharmacotherapy in treatment trials for alcohol dependence, by Carlo C. DiClemente; (5) Synopsis of promising medications to treat alcoholism, by Robert M. Swift; and (6) New knowledge on the development of antiepileptic medications for the treatment of alcoholism, by Robert J. Malcolm, Jr.

Original languageEnglish (US)
Pages (from-to)295-301
Number of pages7
JournalAlcoholism: Clinical and Experimental Research
Volume28
Issue number2
DOIs
StatePublished - Feb 2004

Keywords

  • Alcohol
  • Biomarkers
  • Craving
  • Ondansetron
  • Topiramate

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Development of Novel Pharmacotherapies for the Treatment of Alcohol Dependence: Focus on Antiepileptics'. Together they form a unique fingerprint.

Cite this